Cetera Advisor Networks’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$329K Sell
7,637
-3,710
-33% -$160K ﹤0.01% 2221
2023
Q4
$472K Buy
+11,347
New +$430K ﹤0.01% 1919
2023
Q1
Sell
-4,968
Closed -$203K 2684
2022
Q4
$203K Buy
+4,968
New +$207K ﹤0.01% 2249
2022
Q3
Sell
-4,863
Closed -$204K 2185
2022
Q2
$204K Sell
4,863
-27
-0.6% -$1.13K ﹤0.01% 1848
2022
Q1
$221K Sell
4,890
-70
-1% -$3.08K ﹤0.01% 1822
2021
Q4
$229K Buy
+4,960
New +$235K ﹤0.01% 1788
2020
Q3
Sell
-410
Closed -$18K 3058
2020
Q2
$18K Buy
+410
New +$16.9K ﹤0.01% 2462
2018
Q4
Sell
-5,134
Closed -$251K 1153
2018
Q3
$251K Buy
+5,134
New +$243K 0.01% 940

Other funds holding XPH

Cetera Advisor Networks's XPH Position: Q1 2024 in Review

Cetera Advisor Networks reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 33% in Q1 2024, selling an estimated $160K and leaving 7,637 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #2221.

Cetera Advisor Networks first reported a position in XPH in Q3 2018 and has held it in 8 quarters since. The position peaked at $472K in Q4 2023. 73 funds tracked by Wall St. Rank hold XPH as of Q1 2024.

  • Cetera Advisor Networks held 7,637 shares of State Street SPDR S&P Pharmaceuticals ETF worth $329K as of Q1 2024.
  • Cetera Advisor Networks sold 3,710 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2024, an estimated $160K.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2221 holding.
  • Cetera Advisor Networks first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2018 and has held it in 8 quarters since.
  • Cetera Advisor Networks's State Street SPDR S&P Pharmaceuticals ETF position peaked at $472K in Q4 2023.
  • 73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.